BIPROGY KK header image

BIPROGY KK

8056

Equity

ISIN JP3754200008 / Valor 762755

Tokyo Stock Exchange (2024-11-21)
JPY 4,322.00-0.14%

BIPROGY KK
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

BIPROGY Inc., with a history spanning over six decades since launching Japan's first commercial computers, has played a pivotal role in shaping and advancing the country's information service industry. The company specializes in developing systems and providing Information and Communication Technology (ICT) services that are integral to both societal and industrial support. Leveraging its extensive experience and proven track record, BIPROGY actively collaborates with its clients and other businesses to foster value creation aimed at enriching society, while also striving towards sustainability. The firm is deeply invested in research and innovation, with its Technology Research & Innovation Center dedicated to the global evaluation of technologies, their strategic integration, and the rapid advancement of research activities. This center also emphasizes the importance of nurturing highly skilled researchers, ensuring the company remains at the forefront of technological expertise and innovation.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.08.2024):

Revenue Growth

BIPROGY KK reported a significant increase in revenue for the first quarter of fiscal year 2025, ending June 30, 2024. The company achieved a revenue of 88,352 million yen, marking a 10.6% rise compared to the same period in the previous year, which recorded 79,854 million yen.

Operating Profit

In the first quarter of fiscal year 2025, BIPROGY KK's operating profit saw a notable increase. The company reported an operating profit of 6,578 million yen, representing a 12.8% growth from the 5,829 million yen reported in the first quarter of fiscal year 2024.

Profit Before Tax

BIPROGY KK's profit before tax for the first quarter of fiscal year 2025 was 7,129 million yen, which is a 10.8% increase from the 6,434 million yen reported in the same quarter of the previous year. This indicates a strong financial performance for the company.

Profit Attributable to Owners

The profit attributable to owners of BIPROGY KK for the first quarter of fiscal year 2025 was 4,892 million yen. This reflects a 12.1% increase compared to the 4,365 million yen reported in the first quarter of fiscal year 2024, showcasing the company's profitability.

Dividends

BIPROGY KK has maintained its dividend forecast for fiscal year 2025. The company plans to distribute a total annual dividend of 100 yen per share, with 50 yen each at the end of the second quarter and the year-end, consistent with the previous fiscal year's dividend distribution.

Summarized from source with an LLMView Source

Key figures

5.26%1Y
23.8%3Y
21.2%5Y

Performance

35.1%1Y
30.0%3Y
33.3%5Y

Volatility

Market cap

2811 M

Market cap (USD)

Daily traded volume (Shares)

353,600

Daily traded volume (Shares)

1 day high/low

4355 / 4276

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Okta Inc
Okta Inc Okta Inc Valor: 36082513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%USD 76.57
Repligen Corp
Repligen Corp Repligen Corp Valor: 965900
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%USD 142.58
Vera Therapeutics Inc
Vera Therapeutics Inc Vera Therapeutics Inc Valor: 111319498
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.72%USD 48.31
Plug Power Inc
Plug Power Inc Plug Power Inc Valor: 13074688
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.59%USD 1.92
Concentrix Corporation
Concentrix Corporation Concentrix Corporation Valor: 58052752
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
10.52%USD 43.72
Roku Inc
Roku Inc Roku Inc Valor: 38183498
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 69.20
Littelfuse Inc
Littelfuse Inc Littelfuse Inc Valor: 947930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.16%USD 243.82
Coherent Corp
Coherent Corp Coherent Corp Valor: 121251014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.26%USD 105.72
Universal Display Corp
Universal Display Corp Universal Display Corp Valor: 410257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%USD 168.41
Advanced Energy Industries Inc
Advanced Energy Industries Inc Advanced Energy Industries Inc Valor: 99316
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.36%USD 115.19